CS logo
small CS logo
Providence Portland Medical Center

Portland, Oregon, United States
Medical center in Portland, Oregon
4805 NE Glisan St, Portland, OR 97213

About Providence Portland Medical Center


"Providence Portland Medical Center is part of Providence Health & Services in Oregon, a not-for-profit network of hospitals, health plans, physicians, clinics and affiliated health services. We are recognized for excellence in patient care and research in areas such as cancer, heart, orthopedics, women's health, rehabilitation services and behavioral health"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
152
Alliance for Clinical Trials in Oncology
38
Providence Health & Services
36
SWOG Cancer Research Network
36
Bristol-Myers Squibb
30
ECOG-ACRIN Cancer Research Group
20
Seagen Inc.
13
NRG Oncology
10
Hoffmann-La Roche
8
Janssen Research & Development, LLC
8
Radiation Therapy Oncology Group
8
Total Rows: 100

Clinical Trials at Providence Portland Medical Center


During the past decade, Providence Portland Medical Center conducted 308 clinical trials. In the 10-year time frame, 308 clinical trials started and 176 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 110 clinical trials started and 92 clinical trials were completed. i.e. 83.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years30303535404039395454626228281616448824241212151525252424303021211717Started TrialsCompleted Trails2015201620172018201920202021202220230255075
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Long-Term Outcomes of HIV-Positive Patients
1999-03-01
2006-09-01
Completed
3,669
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
1999-04-01
2013-09-01
Completed
36
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
2000-03-01
2008-11-01
Completed
4,150
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
2000-05-19
2010-01-27
Completed
3,436
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
2001-12-01
Suspended
48
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
2002-11-01
Terminated
1,320
Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
2003-08-01
2007-06-01
Completed
110
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066

Rows per page:

1–100 of 548

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Providence Portland Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 152 trials, followed by "Alliance for Clinical Trials in Oncology" with 38 trials sponsored, "Providence Health & Services" with 36 trials sponsored, "SWOG Cancer Research Network" with 36 trials sponsored and "Bristol-Myers Squibb" with 36 trials sponsored. Other sponsors include 251 different institutions and companies that sponsored additional 128 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Portland Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 136 trials as a collaborator, "NRG Oncology" with 42 trials as a collaborator, "Merck Sharp & Dohme LLC" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 13 trials as a collaborator and "Bristol-Myers Squibb" with 12 trials as a collaborator. Other collaborators include 211 different institutions and companies that were collaborators in the rest 127 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Providence Portland Medical Center


According to Clinical.Site data, the most researched conditions in "Providence Portland Medical Center" are "Melanoma" (27 trials), "Breast Cancer" (19 trials), "Prostate Cancer" (16 trials), "Head and Neck Squamous Cell Carcinoma" (14 trials) and "Head and Neck Cancer" (13 trials). Many other conditions were trialed in "Providence Portland Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Providence Portland Medical Center


Most popular intervention types in "Providence Portland Medical Center" are "Drug" (428 trials), "Biological" (194 trials), "Other" (184 trials), "Procedure" (93 trials) and "Radiation" (76 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (87 trials), "Quality-of-Life Assessment" (75 trials), "Nivolumab" (52 trials), "Questionnaire Administration" (44 trials) and "Computed Tomography" (41 trials). Other intervention names were less common.

Clinical Trials Genders at Providence Portland Medical Center


The vast majority of trials in "Providence Portland Medical Center" are 470 trials for "All" genders, 56 trials for "Female" genders and 22 trials for "Male" genders.

Clinical Trials Status at Providence Portland Medical Center


Currently, there are NaN active trials in "Providence Portland Medical Center". 1 are not yet recruiting, 138 are recruiting, 176 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 165 completed trials in Providence Portland Medical Center, 13 suspended trials, and 47 terminated clinical trials to date.
Out of the total trials that were conducted in Providence Portland Medical Center, 107 "Phase 1" clinical trials were conducted, 257 "Phase 2" clinical trials and 220 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status

Departments of Providence Portland Medical Center


Providence Portland Medical Center has several departments that took part in Clinical trials: "Providence Cancer Center at Providence Portland Medical Center" - 135 trials, "Columbia Basin Hematology" - 93 trials, "Clackamas Radiation Oncology Center" - 255 trials, "Kadlec Clinic Hematology and Oncology" - 223 trials, "Providence Cancer Institute Clackamas Clinic" - 190 trials, "Providence Cancer Center" - 50 trials, "Providence Heart and Vascular Institute" - 37 trials, "Providence Cancer Center at PMCC" - 13 trials, "Cancer Care Associates" - 6 trials, "Kadlec Clinic Rheumatology" - 3 trials, "Providence Sacred Heart Medical Center Wound Clinic" - 2 trials, "Providence Health & Services Cancer Clinical Trials" - 2 trials